CD34 and myelodysplastic syndrome: In this work, we performed single-cell RNA-sequencing (scRNA-seq) in primary CD34+ hematopoietic progenitor cells from del(5q) MDS patients at diagnosis and patients after lenalidomide treatment, and applied copy number alteration (CNA) analyses to link the del(5q) genotype to the transcriptional profile of each individual cell.